Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.23.436684Source: DataRank Database

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

cellosaurus pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (43)IDs (PubMed, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (29)

Anna J. MacCamy ORCID,Nicholas R. Akins,Junli Feng ORCID,Leah J. Homad ORCID,Nicholas K. Hurlburt ORCID

Live enrichment

PubMed:33791692 OpenAlex:https://openalex.org/W3137681283

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 3P51OD011132-64S2

Renovation to expand and enhance NHP housing for HIV/AIDS research at the Emory NPRC

National Institutes of Health

Grant: 3U19AI057266-17S1

Vaccine Induced Immunity in the Young and Aged

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/03/24/2021.03.23.436684.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.23.436684

repositoryhttps://doi.org/10.1101/2021.03.23.436684

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33791692

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyAnimal Virus Infections Studies0301 basic medicine03 medical and health sciences

Keywords

VirologyAntibodyEpitopeNeutralizing antibodyNeutralizationCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyCoronavirus disease 2019 (COVID-19)ImmunologyMedicineInfectious disease (medical specialty)QH301-705.5Cross ReactionsAntibodies, ViralArticleRBDCell LineS2 subunitEpitopesMiceProtein DomainsNeutralization TestsAnimalsHumansBiology (General)Binding SitesSARS-CoV-2SARS-CoV-1Antibodies, MonoclonalCOVID-19Antibodies, NeutralizingNTDHEK293 CellsSpike Glycoprotein, CoronavirusFemaleAngiotensin-Converting Enzyme 2Protein Binding

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

FAIR Checklist

Authors (29)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)